1. Reference
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet.395(10223):497-506.
2. of the International CSG (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology.1.
3. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. (2000) A novel angiotensin-converting enzyme–related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circulation research.87(5):e1-e9.
4. Boehm M, Nabel EG (2002) Angiotensin-converting enzyme 2—a new cardiac regulator. New England Journal of Medicine.347(22):1795-7.
5. Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. (2020) The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv.
6. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W (2020) Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv.
7. Ge X-Y, Li J-L, Yang X-L, Chmura AA, Zhu G, Epstein JH, et al. (2013) Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature.503(7477):535-8.
8. Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, Katovich MJ, et al. (2008) Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension.51(3):712-8.
9. Coleman CM, Liu YV, Mu H, Taylor JK, Massare M, Flyer DC, et al. (2014) Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine.32(26):3169-74.
10. Chen W-H, Chag SM, Poongavanam MV, Biter AB, Ewere EA, Rezende W, et al. (2017) Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate. Journal of pharmaceutical sciences.106(8):1961-70.
11. Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JI-P, et al. (2020) Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. Journal of clinical medicine.9(3):623.
12. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. (2020) Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host & Microbe.
13. Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, et al. (2020) Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerging Microbes & Infections.9(1):382-5.
14. Ter Meulen J, Van Den Brink EN, Poon LL, Marissen WE, Leung CS, Cox F, et al. (2006) Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS medicine.3(7).
15. Kunik V, Ashkenazi S, Ofran Y (2012) Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure. Nucleic acids research.40(W1):W521-W4.
16. Ashkenazy H, Abadi S, Martz E, Chay O, Mayrose I, Pupko T, et al. (2016) ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic acids research.44(W1):W344-W50.
17. Zhang QC, Deng L, Fisher M, Guan J, Honig B, Petrey D (2011) PredUs: a web server for predicting protein interfaces using structural neighbors. Nucleic acids research.39(suppl_2):W283-W7.
18. Chen H, Zhou HX (2005) Prediction of interface residues in protein–protein complexes by a consensus neural network method: test against NMR data. Proteins: Structure, Function, and Bioinformatics.61(1):21-35.
19. Fernández‐Recio J (2011) Prediction of protein binding sites and hot spots. Wiley Interdisciplinary Reviews: Computational Molecular Science.1(5):680-98.
20. Sanchez-Garcia R, Sorzano COS, Carazo JM, Segura J (2019) BIPSPI: a method for the prediction of partner-specific protein–protein interfaces. Bioinformatics.35(3):470-7.
21. Kawabata T (2010) Detection of multiscale pockets on protein surfaces using mathematical morphology. Proteins: Structure, Function, and Bioinformatics.78(5):1195-211.
22. Qin S, Zhou H-X (2007) meta-PPISP: a meta web server for protein-protein interaction site prediction. Bioinformatics.23(24):3386-7.
23. Zhou H-X, Qin S (2007) Interaction-site prediction for protein complexes: a critical assessment. Bioinformatics.23(17):2203-9.
24. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature protocols.4(7):1073.
25. Dunbar J, Krawczyk K, Leem J, Marks C, Nowak J, Regep C, et al. (2016) SAbPred: a structure-based antibody prediction server. Nucleic acids research.44(W1):W474-W8.
26. De Vries SJ, Van Dijk M, Bonvin AM (2010) The HADDOCK web server for data-driven biomolecular docking. Nature protocols.5(5):883.
27. Yuan M, Wu NC, Zhu X, Lee C-CD, So RT, Lv H, et al. (2020) A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV. Science.
28. Jones DS, Silverman AP, Cochran JR (2008) Developing therapeutic proteins by engineering ligand–receptor interactions. Trends in biotechnology.26(9):498-505.
29. Payandeh Z, Rajabibazl M, Mortazavi Y, Rahimpour A, Taromchi AH (2018) Ofatumumab monoclonal antibody affinity maturation through in silico modeling. Iranian biomedical journal.22(3):180.
30. Payandeh Z, Rajabibazl M, Mortazavi Y, Rahimpour A, Taromchi AH, Dastmalchi S (2019) Affinity maturation and characterization of the ofatumumab monoclonal antibody. Journal of cellular biochemistry.120(1):940-50.
31. Lei C, Fu W, Qian K, Li T, Zhang S, Ding M, et al. (2020) Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig. Biorxiv.
32. Alhenc-Gelas F, Drueke TB (2020) Blockade of SARS-CoV-2 infection by recombinant soluble ACE2. Kidney International.
33. Keller MA, Stiehm ER (2000) Passive immunity in prevention and treatment of infectious diseases. Clinical microbiology reviews.13(4):602-14.
34. Antikainen NM, Martin SF (2005) Altering protein specificity: techniques and applications. Bioorganic & medicinal chemistry.13(8):2701-16.
35. Edelheit O, Hanukoglu A, Hanukoglu I (2009) Simple and efficient site-directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies. BMC biotechnology.9(1):61.
36. Eyvazi S, Payandeh Z, Khalili S, Sefid F, Ouladsahebmadarek E (2019) Bevacizumab Antibody Affinity Maturation to Improve Ovarian Cancer Immunotherapy: In Silico Approach. International Journal of Peptide Research and Therapeutics.25(4):1417-30.
2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
3. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
4. A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
5. Angiotensin-Converting Enzyme 2 — A New Cardiac Regulator